Katherine B Peters

Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a rando...

Neurocognitive outcomes in patiënten met brain metastases: a systematic review.

Vorasidenib bij IDH1/2-gemuteerd laaggradige glioom: INDIGO fase III